ON DEMAND Webinar

Cell and gene therapies: How can their promise be realized?

CGT21

The pipeline of advanced therapy is expanding at a rate never seen before, with a number of cell and gene therapies now reaching the market. As a result, the services required to develop them are in more demand than ever. In this webinar we take a look at some of the promising therapies in development, and what is needed to ensure reliable, consistent and scalable manufacturing so that the price of these treatments can be reduced and they can become mainstream.

Speakers

Jane Byrne Jane Byrne Senior Editor
BioPharma-Reporter

Arun Upadhyay, PhD Arun Upadhyay, PhD Vice President and Head of Research and Development
Ocugen

Sanjay Sanjay Srivastava, PhD Managing Director, Cell & Gene Therapy CoE Lead
Accenture

Matthew Durdy Matthew Durdy CEO
Cell and Gene Therapy Catapult